Miscarriage

New tiopronin delayed-release tablets launch with patient support for the treatment of cystinuria in the US

Retrieved on: 
Lundi, mai 13, 2024
FDA, Health, Research, Pharmaceutical, Science, Biotechnology, Partnership, Incidence, Patient, Rash, Lymphadenopathy, Full, Diarrhea, Birth, Milk, Label, Generic, Risk, Tiopronin, Food, Pregnancy, Education, Nausea, Glomerulonephritis, Fever, Arthralgia, SVP, Vomiting, Tablet, Cystinuria, Torrent, Kidney stone disease, Kidney, Breastfeeding, Miscarriage, Proteinuria, Fatigue, Hyperthermia, Child, Lactation, Cycle, Use, Nephrotic syndrome, Birth control

In addition, a Patient Nutrition Program* will be available to reinforce the clinic’s nutrition plan,” says Chikai Lai, SVP & Chief Commercial Officer, Cycle.

Key Points: 
  • In addition, a Patient Nutrition Program* will be available to reinforce the clinic’s nutrition plan,” says Chikai Lai, SVP & Chief Commercial Officer, Cycle.
  • Alcohol: Tiopronin is released faster from tiopronin delayed-release tablets in the presence of alcohol and the risk for adverse events associated with tiopronin delayed-release tablets when taken with alcohol is unknown.
  • Because of the potential for serious adverse reactions, including nephrotic syndrome, advise patients that breastfeeding is not recommended during treatment with tiopronin delayed-release tablets.
  • Tiopronin delayed-release tablets are not approved for use in pediatric patients weighing less than 20 kg or in pediatric patients unable to swallow tablets.

Significant Negative Economic and Personal Impact of "Life Change Events" on Employees and Employers Alike, ApiaryLife Survey Finds

Retrieved on: 
Jeudi, avril 11, 2024
Professional Services, Business, Other Professional Services, Insurance, Human Resources, Finance, Personal Finance, University, Cancer, Grief, Health, WebMD, Workplace, Research, Appetite, Miscarriage, Dementia, Life, Divorce, Literature, Mental health, Presenteeism, Headache, Fatigue, Caregiver, Child, Absenteeism, Person, Prevalence

The survey also identifies high negative impact on caretakers of affected individuals.

Key Points: 
  • The survey also identifies high negative impact on caretakers of affected individuals.
  • Based on responses from over 500 employees, the survey then confirms these economic and emotional effects via a review of extensive literature on the same topics.
  • Katie also spoke of a few occasions where ApiaryLife experts have saved employee users hundreds of thousands of dollars in corrected mistakes in paperwork!
  • Employer Impact: The high costs to employers of such less-productive work scenarios is obvious with other illnesses, such as cancer.

AMGEN TO PRESENT TEZSPIRE® PHASE 2A COPD DATA AT ATS 2024

Retrieved on: 
Mardi, avril 16, 2024
Fetus, AMGN, American Thoracic Society, Congress, Arthralgia, ATS, Chronic obstructive pulmonary disease, Emphysema, Pregnancy, Infection, Tezepelumab, PDT, Allergic conjunctivitis, Amgen, Research and development, Back pain, Conference, Placentalia, Vaccine, Miscarriage, Development, Ageing, Helminthiasis, Incidence, Patient, Anaphylaxis, Hypersensitivity, Rash, Pharyngitis, Birth, Asthma, Bronchitis, AstraZeneca, Excipient, Pharmaceutical industry

THOUSAND OAKS, Calif., April 16, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today provided an update regarding the results of the Phase 2a COURSE trial for TEZSPIRE® (tezepelumab-ekko) in chronic obstructive pulmonary disease (COPD), which were accepted for presentation in the Clinical Trials Symposium at The American Thoracic Society (ATS) 2024 International Conference on Monday, May 20, from 9:15-11:15 a.m. PDT. 

Key Points: 
  • Overall, tezepelumab numerically reduced the annualized rate of moderate or severe COPD exacerbations versus placebo by 17% (90% CI: −6, 36; p=0.1042).
  • Of note, more reductions were observed in a prespecified subgroup of patients with BEC ≥150 cells/μL (37% [95% CI: 7, 57]).
  • The trend in reduction was greater in a small number of subjects with BEC ≥300 cells/µL.
  • We look forward to presenting the full data set at the congress and based on these findings, we are actively planning for the Phase 3 development of tezepelumab in COPD.

Lava for Good Podcasts Garners Webby Nominations for 'The War on Drugs' and Honors for 'Earwitness'

Retrieved on: 
Jeudi, avril 4, 2024
War on Drugs, Webby Awards, Depression, Music, Partnership, Name, Public, Dignity, Humour, Human, Season, Season 2, Justice, War, Good, Pain management, Legislation, Sport, Miscarriage, Public service, PTSD, Entertainment

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Lava for Good Podcasts is honored by the latest accolades in the digital world.

Key Points: 
  • NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Lava for Good Podcasts is honored by the latest accolades in the digital world.
  • The latest recognition for The War on Drugs is particularly timely, as Lava for Good has commenced production of Season 2 for release this fall.
  • These nominations and honors add to Lava for Good’s long list of accolades, including past recognition at the Webby Awards, Ambie Awards, Signal Awards, and iHeartPodcast Awards.
  • For more information on The War on Drugs, Earwitness, and other Lava for Good podcasts, visit www.lavaforgood.com or find them on all popular podcast platforms.

Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires

Retrieved on: 
Lundi, avril 8, 2024
Diabetes, Anaphylaxis, IgA nephropathy, Glaucoma, CYP3A4, Dermatitis, Patient, Parasitism, Indinavir, Budesonide, Ritonavir, Quality of life, Peripheral edema, UPCR, Drug interaction, Vaccine, Saquinavir, Erythromycin, Congress, White, Risk, Headache, Spasm, Ketoconazole, Immunoglobulin A, Liver, Adrenal insufficiency, Immune system, Prediabetes, Proteinuria, Hypertension, Contraindication, Arthralgia, Ciclosporin, International Society, Immunosuppression, KOL, Acne, Infection, EGFR, Measles, Miscarriage, ISN, Hypersensitivity, Pregnancy, HPA, Chickenpox, Fetus, Birth, Itraconazole, CALT, Upper respiratory tract infection, Osteoporosis, Kidney, Cataract, Tropical ulcer, Pharmaceutical industry

The ISN World Congress of Nephrology will be held in Buenos Aires, Argentina April 13-16, 2024.

Key Points: 
  • The ISN World Congress of Nephrology will be held in Buenos Aires, Argentina April 13-16, 2024.
  • Presentations will highlight the eGFR results found in patients on Nefecon as well as the data on quality of life during the trial.
  • There will also be a presentation on the subanalysis evaluating benefits of Nefecon for patients with lower levels of UPCR.
  • The congress will include a symposium, Evolving Landscape of eFGR and Proteinuria Surrogate Markers in IgA Nephropathy, moderated by KOL Richard Lafayette, M.D., F.A.C.P.

Calliditas Therapeutics to Present Nefecon Data at the ISN World Congress of Nephrology April 13 - 16 in Buenos Aires

Retrieved on: 
Lundi, avril 8, 2024
Diabetes, Anaphylaxis, IgA nephropathy, Glaucoma, CYP3A4, Dermatitis, Patient, Parasitism, Indinavir, Budesonide, Ritonavir, Quality of life, Peripheral edema, UPCR, Drug interaction, Vaccine, Saquinavir, Erythromycin, Congress, White, Risk, Headache, Spasm, Ketoconazole, Immunoglobulin A, Liver, Adrenal insufficiency, Immune system, Prediabetes, Proteinuria, Hypertension, Contraindication, Arthralgia, Ciclosporin, International Society, Immunosuppression, KOL, Acne, Infection, EGFR, Measles, Miscarriage, ISN, Hypersensitivity, Pregnancy, HPA, Chickenpox, Fetus, Birth, Itraconazole, CALT, Upper respiratory tract infection, Osteoporosis, Kidney, Cataract, Tropical ulcer, Pharmaceutical industry

The ISN World Congress of Nephrology will be held in Buenos Aires, Argentina April 13-16, 2024.

Key Points: 
  • The ISN World Congress of Nephrology will be held in Buenos Aires, Argentina April 13-16, 2024.
  • Presentations will highlight the eGFR results found in patients on Nefecon as well as the data on quality of life during the trial.
  • There will also be a presentation on the subanalysis evaluating benefits of Nefecon for patients with lower levels of UPCR.
  • The congress will include a symposium, Evolving Landscape of eFGR and Proteinuria Surrogate Markers in IgA Nephropathy, moderated by KOL Richard Lafayette, M.D., F.A.C.P.

Menstrual health literacy is alarmingly low – what you don’t know can harm you

Retrieved on: 
Mercredi, mars 13, 2024
Well, Meigs's syndrome, Anxiety, Premenstrual dysphoric disorder, Woman, Bleeding, Diet, Menstrual cycle, Education, Anemia, Temperature, Inflammation, Hormone, Pain, Fetus, Hysterical, Female, Growth, Endometriosis, Asthma, Menstruation, Swelling, Human, Femininity, Physiology, Pregnancy, Fibroid, Syndrome, Migraine, Irritable bowel syndrome, Ovulation, Premenstrual syndrome, Puberty, Mother, Mammal, Patient, Employment, Prisoner, Miscarriage, Medicine, Epilepsy, Health literacy, Urine, Science, Vagina, Biology, Mortality, Research, Depression, Birth control

When I ask my menstrual health workshop participants – including clinicians – there’s usually a lot of shrugging and shaking of heads.

Key Points: 
  • When I ask my menstrual health workshop participants – including clinicians – there’s usually a lot of shrugging and shaking of heads.
  • If given multiple choice options, most think that periods either “clean the womb” or somehow “help prepare for pregnancy”.
  • Yes, the blood part can stain clothing, but there is nothing pathological, contaminating, or dangerous about periods.

So, why do we have periods?

  • Periods likely evolved as a kind of preemptive abortion, to protect women from unviable or dangerous pregnancies.
  • As a result, we have low rates of conception, high rates of miscarriage, and extremely high rates of maternal mortality in comparison to other mammals.
  • The menstrual cycle is critical for facilitation of the initial steps of this raison d’être of the female reproductive system.
  • The menstrual cycle is critical for facilitation of the initial steps of this raison d’être of the female reproductive system.

What else don’t we know?

  • Perhaps with the fact that the second phase of the cycle from ovulation to menstruation is a series of highly inflammatory processes.
  • This was only very briefly mentioned in three out of 16 textbooks.
  • We really ought to be taught from puberty how to reduce period pain and blood loss – this is not difficult science.

Why aren’t we taught this stuff?

  • My research shows that the exclusive focus on the female sex hormones in menstrual education is informed by societal influences, such as the myth of the hysterical or hormonal female.
  • This gender myth is still alive and well, although now we tend to blame the (female sex) hormones.
  • Again, there was no scientific reason for this change in focus, although it reflected existing societal beliefs about the inherently irrational behaviour of women.
  • Unfortunately, menstrual health literacy has not yet recovered from this shift in physiological models.

So what?

  • It also becomes much easier to differentiate premenstrual changes from underlying health conditions, since the latter will not be substantially alleviated by anti-inflammatory interventions alone.
  • Teaching the reductive hormonal model of the menstrual cycle unintentionally provides pseudo-scientific evidence for the damaging hormonal or hysterical female gender myth.


Sally King is the founder of Menstrual Matters- the world's first evidence-based info hub on menstrual health and rights www.menstrual-matters.com. Her doctoral research and current research fellowship were funded by the ESRC (Economic and Social Research Council).

Canada’s inaction in Gaza marks a failure of its feminist foreign policy

Retrieved on: 
Mercredi, mars 13, 2024
Malnutrition, Woman, Violence, Hamas, Failure, Poverty, RCMP, Pregnancy, Feminism, Sale, FIAP, Empowerment, Maternal death, Rape, Food, Risk, Safety, Health, Global Affairs Canada, United Nations, Stillbirth, Foreign Affairs, Non-governmental organization, Infant, Mother, Policy, Miscarriage, UN, Reproductive rights, Joly, Water, Face, Birth control

“Peace and prosperity are every person’s birthright.” So opened then Minister of Foreign Affairs Chrystia Freeland’s introduction to Canada’s Feminist International Assistance Policy (FIAP).

Key Points: 
  • “Peace and prosperity are every person’s birthright.” So opened then Minister of Foreign Affairs Chrystia Freeland’s introduction to Canada’s Feminist International Assistance Policy (FIAP).
  • Launched in 2017, the policy stated that Canada would take an explicitly feminist approach to international assistance, including a commitment to protecting women’s sexual and reproductive rights.
  • Many considered it to be a forward-thinking policy that builds on the past work of NGOs and other international partners.
  • In addition to funding, Joly also offered RCMP support to help investigate the crimes of sexual violence against Israeli women.

Palestinian women’s rights long ignored

  • Her statement came after United Nations experts expressed alarm over “credible allegations of egregious human rights violations to which Palestinian women and girls continue to be subjected in the Gaza Strip and the West Bank.” They cited reports of arbitrary executions, killings, detentions and sexual abuse of Palestinian women and girls by Israeli forces.
  • Even before the current escalation of violence, Canada’s support of Israel’s actions have long been identified as a significant limitation of FIAP.
  • Palestinian women also face increased risk of sexual violence.
  • There are credible reports of sexual violence being used as a tool of war against both Israeli and Palestinian women.

Reproductive health in Gaza in a dire state

  • An estimated 50,000 pregnant women in Gaza are at increased risk of miscarriage, stillbirth and maternal death.
  • The widespread food crisis has also had dire implications for reproductive and maternal health.
  • Malnutrition affects maternal health, and can also have long-term consequences for the health of mothers and their children.

Canada must act

  • Meanwhile, Canadian exports of military equipment to Israel have not only continued, but have increased since October.
  • Global Affairs Canada claims these exports are only for non-lethal equipment.
  • Canada’s delayed and inconsistent response to Israel’s military violence in Gaza represents a failure to evenly apply its own foreign policy.
  • If Canada truly wants to create a more peaceful and prosperous world, they must not leave Palestinian women behind.


Jacqueline Potvin previously received funding from Social Sciences and Humanities Research Council. Mayme Lefurgey does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Hagens Berman: Lawsuit Accuses Oregon Port, Commercial Farms and Animal Feeding Operation of Contaminating Groundwater, Putting Tens of Thousands of Oregonians at Risk

Retrieved on: 
Mercredi, février 28, 2024
Legal, Class Action Lawsuit, Concentrated animal feeding operation, Soil, Filtration, Natural Resources, Nitrate, Pregnancy, Methemoglobinemia, District court, Cooking, Learning, Groundwater, Behavior, Drinking, City, Drinking water, Environmental quality, EPA, Agriculture, DEQ, GMA, Farm, Nitrogen, Manure, Thyroid, Miscarriage, Water, Cancer, Sewage treatment

Between Nov. 1, 2023, and Jan. 11, 2024, alone, the Port violated its permit at least 395 times, the lawsuit states.

Key Points: 
  • Between Nov. 1, 2023, and Jan. 11, 2024, alone, the Port violated its permit at least 395 times, the lawsuit states.
  • Attorneys say the Port of Morrow, commercial farms, and CAFOs have allegedly contributed to “soaring” levels of nitrates in local groundwater.
  • “The Port and these commercial farms have placed us and hundreds of other families in an impossible position.
  • The lawsuit states that in 1990, the Oregon DEQ declared the Lower Umatilla Basin a groundwater management area (GMA).

FOX News Books to Release Its Tenth Title With “Love, Mom” by Dr. Nicole Saphier

Retrieved on: 
Mercredi, février 14, 2024
Entertainment, Communications, TV and Radio, General Entertainment, Books, Media, Publishing, Fox News, Daughter, Collection, Love, Politics, Television, Weill Cornell Medicine, Fox Corporation, Fox, Radiology, Weather, FNC, Fox Business, FBN, Fox Weather, Woman, Fox Nation, Mother, News, Health policy, Miscarriage, Child, Cancer

FOX News Books, the publishing imprint for FOX News Media, will release its tenth book on April 16th, entitled “Love, Mom” by FOX News Channel’s medical contributor and mother of three, Dr. Nicole Saphier.

Key Points: 
  • FOX News Books, the publishing imprint for FOX News Media, will release its tenth book on April 16th, entitled “Love, Mom” by FOX News Channel’s medical contributor and mother of three, Dr. Nicole Saphier.
  • Some are a part of the FOX News family, others are from personal and professional interactions, and some from our amazing viewers.
  • Notably, nearly every FOX News Books title has placed on multiple national bestseller lists and shot to number one on Amazon.
  • FOX News Media operates the FOX News Channel (FNC), FOX Business Network (FBN), FOX News Digital, FOX News Audio, FOX News Books, the direct-to-consumer streaming services FOX Nation and FOX News International and the free ad-supported television service FOX Weather.